Rapidly healing flow diverters using magnetic cell targeting for intracranial aneurysm treatment
使用磁性细胞靶向治疗颅内动脉瘤的快速愈合分流器
基本信息
- 批准号:10508348
- 负责人:
- 金额:$ 21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAneurysmArteriesAutologousBiocompatible MaterialsBiologicalBloodBlood flowCathetersCellsCircle of WillisClinicalClinical ResearchClinical TreatmentComplicationCoronaryDataDevicesDistalElastasesEmbolismEndothelial CellsEndotheliumEvaluationFibrinFutureGoalsHemorrhageImpaired healingInternal carotid artery structureIntracranial AneurysmInvestigationIschemic StrokeLabelLeadLifeMagnetic nanoparticlesMagnetismMeasuresMechanicsMesenchymal Stem CellsModelingMorbidity - disease rateNeckOperative Surgical ProceduresOryctolagus cuniculusOutcomeParentsPatient CarePersonsPreclinical TestingPrincipal InvestigatorPropertyReproducibilityResearchResearch ProposalsRiskRuptureRuptured AneurysmSafetySideSiteStainless SteelStatistical MethodsStentsSurfaceTechniquesTechnologyTestingTherapeutic AgentsTherapeutic EmbolizationThromboembolismThrombosisTranslational ResearchTubular formationUnited StatesVascular GraftWorkbiomaterial compatibilityclinical applicationclinically relevantferritefirst-in-humanhealinghemocompatibilityimprovedimproved outcomein vivoinnovationmagnetic fieldmetallicityminimally invasivemortalitymultidisciplinarynanoparticle deliverynext generationnovelresponserestorationsafety and feasibilitysafety testingside effectstandard of caretargeted deliverytargeted treatmentthrombotictranslational approach
项目摘要
Project Summary
This application focuses on advancing the field of intracranial flow diversion, that currently constitutes
approximately one-third of the treatment of unruptured intracranial aneurysms. There remain key limitations to
the technology that hinder expansion of the clinical application of these transformational devices, which to date
are limited in scope to unruptured, proximal aneurysms along the internal carotid artery. One major barrier is
device-related thrombosis, which can lead to thrombotic or embolic ischemic stroke. This requires administration
of dual anti-platelet therapy, which has the serious side effect of bleeding. Another major barrier is delayed
healing and aneurysm occlusion, which precludes treatment of acutely ruptured aneurysms and necessitates
prolonged anti-platelet therapy. We will break down these barriers to expanded utility by 1) developing a
ferromagnetic flow diverter to enable magnetic targeting of therapeutic agents and 2) testing the safety and
feasibility of rapid device healing by magnetic targeting of autologous endothelial cells. Studies have shown that
endothelialization of the aneurysm neck is critical for long term complete aneurysm occlusion and anti-platelet
therapy can be safely discontinued. We envision that, with our proposed approach, we will facilitate application
of novel, next-generation devices in ruptured aneurysms and in aneurysms distal to the Circle of Willis, and will
minimize thromboembolic risk. We have previously developed magnetic devices including stents, stent-grafts,
and vascular grafts and demonstrated their ability to capture and retain magnetically-labeled endothelial cells.
We will extend our magnetic cell targeting technologies to the application of rapid endothelialization of flow
diverters. Our robust and reproducible methods of statistical evaluation will directly assess 1) device integrity
and functionality, 2) device biocompatibility and hemocompatibility, 3) device magnetic properties, 4) magnetic
cell capture and retention to the devices, and 5) safety and feasibility of rapid endotheliazation and aneurysm
occlusion of magnetically endothelialized flow diverters in an in vivo aneurysm model. The discoveries from this
hypothesis-driven, multidisciplinary, clinical-translational research will provide a robust understanding of the
benefits conferred by rapid endothelization of flow diverters used to treat intracranial aneurysms. The goal of
this research is to reduce the complication rate associated with device-related thrombosis, prolonged anti-platelet
therapy, and delayed aneurysm healing and occlusion. If successful, neurointerventionalists will be able to use
flow diverters to treat a broader range of aneurysms safely and effectively. Optimizing outcomes and minimizing
complications will significantly improve patient care and save lives. A ferromagnetic flow diverter will also enable
future investigations of targeted delivery of other therapeutic agents. For example, fibrin for rapid aneurysm
occlusion, mesenchymal stem cells for rapid healing, and anti-platelet therapy to localize the effects and reduce
systemic bleeding risk. Such investigations have the potential to be transformative in the treatment of intracranial
aneurysms by significantly improving upon the current standard of care.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ramanathan Kadirvel其他文献
Ramanathan Kadirvel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ramanathan Kadirvel', 18)}}的其他基金
Rapidly healing flow diverters using magnetic cell targeting for intracranial aneurysm treatment
使用磁性细胞靶向治疗颅内动脉瘤的快速愈合分流器
- 批准号:
10629368 - 财政年份:2022
- 资助金额:
$ 21万 - 项目类别:
Computational and Biological Approach to Flow Diversion
分流的计算和生物学方法
- 批准号:
8216809 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Computational and Biological Approach to Flow Diversion
分流的计算和生物学方法
- 批准号:
8335380 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Computational and Biological Approach to Flow Diversion
分流的计算和生物学方法
- 批准号:
8533042 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
Computational and Biological Approach to Flow Diversion
分流的计算和生物学方法
- 批准号:
8716821 - 财政年份:2011
- 资助金额:
$ 21万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21万 - 项目类别:
Research Grant














{{item.name}}会员




